Ertugliflozin 25 mg

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Type 2Hypertension

Phase 2

Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)

CompletedNCT01059825

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2010-02-24End: 2011-01-20Updated: 2018-09-13

Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)

CompletedNCT01096667

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2, Hypertension

Start: 2010-05-17End: 2011-02-25Updated: 2018-09-13